Ingevity (NYSE: NGVT) is one of 32 public companies in the “Commodity Chemicals” industry, but how does it contrast to its peers? We will compare Ingevity to related companies based on the strength of its analyst recommendations, profitability, earnings, dividends, institutional ownership, valuation and risk.

Institutional and Insider Ownership

91.4% of Ingevity shares are held by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are held by institutional investors. 0.1% of Ingevity shares are held by company insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Ingevity has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Ingevity’s peers have a beta of 1.14, indicating that their average share price is 14% more volatile than the S&P 500.

Profitability

This table compares Ingevity and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 9.86% 58.14% 12.09%
Ingevity Competitors -29.50% 24.34% 5.63%

Valuation & Earnings

This table compares Ingevity and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $908.30 million $35.20 million 32.62
Ingevity Competitors $4.01 billion $340.26 million 149.04

Ingevity’s peers have higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and target prices for Ingevity and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 0 6 0 3.00
Ingevity Competitors 107 826 1225 36 2.54

Ingevity currently has a consensus price target of $76.00, suggesting a potential upside of 4.94%. As a group, “Commodity Chemicals” companies have a potential downside of 3.66%. Given Ingevity’s stronger consensus rating and higher probable upside, analysts clearly believe Ingevity is more favorable than its peers.

Summary

Ingevity beats its peers on 8 of the 13 factors compared.

Ingevity Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.